Takeaway

• Adding a once-weekly, weight-based dose of azithromycin (AZM) for chronic lung disease treatment of children with perinatally acquired HIV established on antiretroviral therapy (ART) appears to be feasible and is generally well-adhered.

Why this matters

• Although the additional pill burden does...